Onchocerciasis in Burkina Faso: a Re-Emerging Vector-Borne Endemic Disease

被引:2
|
作者
Sawadogo, P. M. [1 ,2 ]
Bougouma, C. [3 ]
Zida, A. [1 ,2 ]
Compaore, J. [3 ]
Guiguemde, T. K. [2 ,4 ]
Sangare, I [6 ,7 ]
Kabore, D. [1 ]
Bamba, S. [6 ,7 ]
Guiguemde, T. R. [5 ]
机构
[1] Ctr Hosp Univ Yalgado Ouedraogo, Serv Parasitol Mycol, 03 BP 7022, Ouaga 03, Burkina Faso
[2] Univ Joseph Ki Zerbo UJKZ, Unite Format & Rech Sci Sante, Ouagadougou, Burkina Faso
[3] Unite Eliminat Onchocercose, Programme Natl Lutte Malad Trop Negligees, Ouagadougou, Burkina Faso
[4] Ctr Hosp Univ Charles de Gaulle, Serv Parasitol Mycol, Ouagadougou, Burkina Faso
[5] Acad Natl Sci Arts & Lettres Burkina Faso ANSAL, Ouagadougou, Burkina Faso
[6] Ctr Hosp Univ Souro Sanou, Serv Parasitol Mycol, Bobo Dioulasso, Burkina Faso
[7] Univ Nazi Boni UNB, Inst Sci Sante, Bobo Dioulasso, Burkina Faso
来源
关键词
D O I
10.3166/bspe-2020-0106
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Burkina Faso, like other countries, reported a focal interruption of onchocerciasis transmission and was thus placed under post-therapeutic surveillance. However, the country seems to be experiencing a resurgence of the disease according to recent surveys at certain sentinel sites and data from various surveys. The aim of our study is to take stock of the evolution of the current epidemiological situation of onchocerciasis in Burkina Faso. For data collection, in addition to the scientific articles, we have used data from different epidemiological and entomological surveys conducted by the National Program for the Control of Neglected Tropical Diseases (PNLMTN) through its onchocerciasis elimination unit in Burkina Faso. Prior to implementation of the Onchocerciasis Control Program in West Africa (OCP), Burkina Faso had onchocerciasis prevalence between 60% and 80%. In 2002, the maximum prevalence dropped to 15%. However, in 2010 and 2011, epidemiological surveys indicated that some villages in the Comoe River basin had prevalence rate ranging from 0.7% to 71%. Thirteen (13) villages had prevalence rates above the tolerable threshold of 5%. Despite the implementation of the community-directed treatment with ivermectin (CDTI) since 2011, recent surveys show a tendency for a recrudescence of the disease in some sites, yet covered by the TIDC. This suggests that the elimination of onchocerciasis requires the integration of new control strategies. Thus, an essential condition for the elimination of onchocerciasis is the analysis of the situation in each focus in order to define the most cost-effective strategy for permanently interrupting the transmission of the parasite. National onchocerciasis elimination committees put in place will play a key role in determining the best strategy.
引用
收藏
页码:260 / 274
页数:15
相关论文
共 50 条
  • [21] VECTOR-BORNE EMERGENT DISEASE
    MONATH, TP
    DISEASE IN EVOLUTION: GLOBAL CHANGES AND EMERGENCE OF INFECTIOUS DISEASES, 1994, 740 : 126 - 128
  • [22] In focus: Vector-borne disease
    Carpenter, Simon
    PEST MANAGEMENT SCIENCE, 2007, 63 (07) : 623 - 624
  • [23] Response to an emerging vector-borne disease: Surveillance and preparedness for Schmallenberg virus
    Roberts, H. C.
    Elbers, A. R. W.
    Conraths, F. J.
    Holsteg, M.
    Hoereth-Boentgen, D.
    Gethmann, J.
    van Schaik, G.
    PREVENTIVE VETERINARY MEDICINE, 2014, 116 (04) : 341 - 349
  • [24] Emerging vector-borne diseases: The diagnostic challenge
    Ford, RB
    VETERINARY TECHNICIAN, 2003, 24 (03): : 183 - 183
  • [25] Emerging feline vector-borne pathogens in Italy
    Giulia Morganti
    Fabrizia Veronesi
    Valentina Stefanetti
    Trentina Di Muccio
    Eleonora Fiorentino
    Manuela Diaferia
    Azzurra Santoro
    Fabrizio Passamonti
    Marina Gramiccia
    Parasites & Vectors, 12
  • [26] Emerging and re-emerging infectious disease
    Drew, WL
    CLINICS IN LABORATORY MEDICINE, 2002, 22 (04) : XI - XI
  • [27] The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso
    Nikiema, Achille S.
    Koala, Lassane
    Sondo, Apoline K.
    Post, Rory J.
    Pare, Alain B.
    Kafando, Claude M.
    Kambire, Roger S.
    Sow, Bazoumana
    Bougouma, Clarisse
    Dabire, Roch K.
    Traore, Soungalo
    PLOS NEGLECTED TROPICAL DISEASES, 2021, 15 (03):
  • [28] EMERGING VECTOR-BORNE VIRUSES DETECTED IN SPAIN
    Vazquez, A.
    Figuerola, J.
    Molina, R.
    Habela, M. A.
    Estrada, A.
    Sierra, M. J.
    Varcalcel, F.
    Olmeda, S.
    Sanchez-Seco, M. P.
    GACETA SANITARIA, 2023, 37 : S40 - S40
  • [29] VECTOR-BORNE EMERGING PATHOGENS - GENERAL DISCUSSION
    MONATH, TP
    ANDERSON, PK
    MORSE, S
    LEVINS, R
    CASH, R
    SPIELMAN, A
    MATA, L
    AWERBUCH, T
    COLWELL, R
    SMITH, G
    PUCCIA, C
    DISEASE IN EVOLUTION: GLOBAL CHANGES AND EMERGENCE OF INFECTIOUS DISEASES, 1994, 740 : 195 - 198
  • [30] Emerging role of doxycycline in vector-borne diseases
    Paula Olivera, Maria
    Faccini-Martinez, Alvaro A.
    Perez-Diaz, Carlos E.
    Rodriguez-Morales, Alfonso J.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 46 (04) : 478 - 479